GR68005B - - Google Patents

Info

Publication number
GR68005B
GR68005B GR61512A GR800161512A GR68005B GR 68005 B GR68005 B GR 68005B GR 61512 A GR61512 A GR 61512A GR 800161512 A GR800161512 A GR 800161512A GR 68005 B GR68005 B GR 68005B
Authority
GR
Greece
Application number
GR61512A
Other languages
Greek (el)
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU81069A external-priority patent/LU81069A1/fr
Priority claimed from LU81068A external-priority patent/LU81068A1/fr
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of GR68005B publication Critical patent/GR68005B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR61512A 1979-03-22 1980-03-22 GR68005B (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU81069A LU81069A1 (fr) 1979-03-22 1979-03-22 Derive de glycinamide, preparation de ce derive, son utilisation ainsi que composition contenant ce derive
LU81068A LU81068A1 (fr) 1979-03-22 1979-03-22 Derives de la glycinamide, leur preparation et utilisation, ainsi que compositions contenant ces derives

Publications (1)

Publication Number Publication Date
GR68005B true GR68005B (cg-RX-API-DMAC10.html) 1981-10-26

Family

ID=26640253

Family Applications (1)

Application Number Title Priority Date Filing Date
GR61512A GR68005B (cg-RX-API-DMAC10.html) 1979-03-22 1980-03-22

Country Status (18)

Country Link
US (1) US4639468A (cg-RX-API-DMAC10.html)
AT (1) AT381302B (cg-RX-API-DMAC10.html)
AU (1) AU536499B2 (cg-RX-API-DMAC10.html)
CA (1) CA1184567A (cg-RX-API-DMAC10.html)
CH (1) CH645091A5 (cg-RX-API-DMAC10.html)
DE (2) DE3010599A1 (cg-RX-API-DMAC10.html)
DK (1) DK162714C (cg-RX-API-DMAC10.html)
ES (1) ES490536A0 (cg-RX-API-DMAC10.html)
FI (1) FI82033C (cg-RX-API-DMAC10.html)
FR (1) FR2451913A1 (cg-RX-API-DMAC10.html)
GB (1) GB2048852B (cg-RX-API-DMAC10.html)
GR (1) GR68005B (cg-RX-API-DMAC10.html)
IE (1) IE49751B1 (cg-RX-API-DMAC10.html)
IL (1) IL59679A (cg-RX-API-DMAC10.html)
NL (1) NL191508C (cg-RX-API-DMAC10.html)
NO (1) NO157817C (cg-RX-API-DMAC10.html)
PT (1) PT70992A (cg-RX-API-DMAC10.html)
SE (1) SE453917B (cg-RX-API-DMAC10.html)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2937698A1 (de) * 1979-09-18 1981-04-02 A. Nattermann & Cie GmbH, 5000 Köln N-propionylsarcosinanilide, deren herstellungsverfahren und arzneimittel auf deren basis
DK373383A (da) * 1982-08-20 1984-02-21 Midit Fremgangsmaade til fremstilling af omega-aminosyrederivater
US4798687A (en) * 1987-02-06 1989-01-17 Pennwalt Corporation 2-Amino-N-[1,2-Diphenyl-1-(thifluoromethyl)ethyl]acetamide derivatives
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers
US4891058A (en) * 1988-07-18 1990-01-02 Ici Americas Inc. 1-alkyl-3-aryl imidazolidine-2,4-diones and herbicidal use
US5278191A (en) * 1988-08-31 1994-01-11 G. D. Searle & Co. Diphenylmethylaminoacetamide derivatives as anti-convulsants
US5288905A (en) * 1988-10-07 1994-02-22 G. D. Searle & Co. Glycyl urea derivatives as anti-convulsants
US4944796A (en) * 1988-11-14 1990-07-31 Ici Americas Inc. Certain 2-(disubstituted amino) acetanilide herbicides
DE3915755A1 (de) * 1989-05-13 1990-11-29 Bayer Ag Fungizide mittel sowie substituierte aminosaeureamid-derivate und deren herstellung
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5075337A (en) * 1989-07-26 1991-12-24 G. D. Searle & Co. Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
DE4102042A1 (de) * 1991-01-24 1992-07-30 Bayer Ag Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide
US5141960A (en) * 1991-06-25 1992-08-25 G. D. Searle & Co. Tricyclic glycinamide derivatives as anti-convulsants
GB9306886D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
GB9306899D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
US5585358A (en) * 1993-07-06 1996-12-17 Yissum Research Development Corporation Of The Hebrew University Of Jerusalem Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
SI1014966T1 (sl) * 1996-05-31 2006-10-31 Allelix Neuroscience Inc Zdravilo za zdravljenje nevroloskih in nevripsihiatricnih bolezni
US6191165B1 (en) * 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
US6984754B1 (en) 1998-03-26 2006-01-10 University Of Saskatchewan Technologies Inc. Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
WO1999048858A2 (en) * 1998-03-26 1999-09-30 University Of Saskatchewan Technologies Inc. Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
US6346547B1 (en) * 1999-02-08 2002-02-12 Checkpoint, Genetics, Inc. N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith
EP1303289A4 (en) * 2000-07-21 2009-08-05 Yissum Res Dev Co USE OF VALPROIC ACID DERIVATIVES AND 2-VALPROENIC ACID AMIDES FOR THE TREATMENT OF MANIE IN CASES OF BIPOLAR DISORDER
ATE301995T1 (de) * 2000-08-17 2005-09-15 Teva Pharma Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
ES2307671T3 (es) * 2000-11-21 2008-12-01 Ucb Pharma, S.A. Compuestos de gaba n-alquilados, procedimientos para su preparacion y su uso como medicamentos.
CN1219776C (zh) 2001-02-16 2005-09-21 阿雷里克斯神经学有限公司 作为glyt-1抑制剂的噻吩取代的胺衍生物
US20030035784A1 (en) * 2001-03-05 2003-02-20 Kao Corporation Hair cosmetic, aminocarboxylic acid amide and method for producing the same
WO2003020273A2 (en) 2001-09-03 2003-03-13 Newron Pharmaceuticals Spa Pharmaceutical composition comprising gabapentin or an analogue thereof and an $g(a)-aminoamide and its analgesic use
EP1438956A1 (en) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
BRPI0515154A (pt) * 2004-09-10 2008-07-08 Newron Pharm Spa uso de (halobenzilóxi)benzilamino-propanamidas para a fabricação de medicamentos ativos, compostos e composição farmacêutica
CN101018843B (zh) * 2004-09-13 2011-05-11 西巴特殊化学品控股有限公司 烷基氨基乙酰胺润滑添加剂
FR2896991A1 (fr) * 2006-02-03 2007-08-10 Inst Nat Sante Rech Med Procede pour preparer un compose organique a l'etat solide et compositions pharmaceutiques comprenant ledit compose organique
CN102351733B (zh) * 2011-07-21 2014-03-19 凯莱英医药化学(阜新)技术有限公司 一种制备2-氨基-n,n-二甲基乙酰胺盐酸盐的方法
CN106795096B (zh) 2014-06-25 2020-05-29 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
JP6053724B2 (ja) * 2014-06-26 2016-12-27 国立大学法人九州大学 イオン交換樹脂及び金属の吸着分離方法
JP7072386B2 (ja) 2015-06-29 2022-05-20 アクイタス セラピューティクス インコーポレイテッド 核酸の送達のための脂質および脂質ナノ粒子製剤
EP4212510A1 (en) 2015-10-28 2023-07-19 Acuitas Therapeutics Inc. Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
CN106187829B (zh) * 2016-07-29 2017-12-15 万华化学集团股份有限公司 一种制备乙二胺基乙磺酸盐的方法
US12491261B2 (en) 2016-10-26 2025-12-09 Acuitas Therapeutics, Inc. Lipid nanoparticle formulations
US11357856B2 (en) 2017-04-13 2022-06-14 Acuitas Therapeutics, Inc. Lipids for delivery of active agents
EP4410317A3 (en) 2017-04-28 2024-10-30 Acuitas Therapeutics Inc. Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
US11639329B2 (en) 2017-08-16 2023-05-02 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
WO2019036028A1 (en) 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
EP4501322A3 (en) 2017-08-17 2025-04-16 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
WO2019036030A1 (en) 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
CA3113449A1 (en) 2018-09-21 2020-03-26 Acuitas Therapeutics, Inc. Systems and methods for manufacturing lipid nanoparticles and liposomes
KR101953366B1 (ko) 2018-12-26 2019-02-28 정종문 침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법
MY202837A (en) 2019-01-11 2024-05-24 Acuitas Therapeutics Inc Lipids for lipid nanoparticle delivery of active agents
USD926577S1 (en) 2019-09-23 2021-08-03 Verdant Ventures Tamper-resistant lid assembly
US11326923B2 (en) 2019-10-08 2022-05-10 Verdant Ventures Tamper-resistant lid assembly for dispensing a premeasured amount of liquid
DK4182297T3 (da) 2020-07-16 2025-12-01 Acuitas Therapeutics Inc Kationiske lipider til brug i lipid-nanopartikler
JP2024546952A (ja) 2021-12-16 2024-12-26 アクイタス セラピューティクス インコーポレイテッド 脂質ナノ粒子製剤に用いるための脂質

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2368208A (en) * 1940-12-16 1945-01-30 Emulsol Corp Chemical compounds and method of preparing same
US2781385A (en) * 1953-09-21 1957-02-12 Gefgy Chemical Corp Diamidocarboxylic acids and certain salts thereof
FI41563B (cg-RX-API-DMAC10.html) * 1962-05-09 1969-09-01 Ferrosan Ab
JPS5319654B2 (cg-RX-API-DMAC10.html) * 1974-03-14 1978-06-22
DE2832009A1 (de) * 1978-07-20 1980-01-31 Deutsches Krebsforsch Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen

Also Published As

Publication number Publication date
FI82033C (fi) 1991-01-10
NO157817B (no) 1988-02-15
DK162714C (da) 1992-04-21
IL59679A0 (en) 1980-06-30
GB2048852B (en) 1983-03-30
ES8104790A1 (es) 1981-04-16
PT70992A (fr) 1980-04-01
FR2451913B1 (cg-RX-API-DMAC10.html) 1984-07-13
DE3050800C2 (cg-RX-API-DMAC10.html) 1989-06-22
NL191508C (nl) 1995-08-21
FI800900A7 (fi) 1980-09-23
DE3010599C2 (cg-RX-API-DMAC10.html) 1989-03-02
ATA154680A (de) 1986-02-15
DK123580A (da) 1980-09-23
NO157817C (no) 1988-05-25
IE49751B1 (en) 1985-12-11
IE800599L (en) 1980-09-22
FR2451913A1 (fr) 1980-10-17
SE8002204L (sv) 1980-09-23
SE453917B (sv) 1988-03-14
ES490536A0 (es) 1981-04-16
NO800830L (no) 1980-09-23
CA1184567A (en) 1985-03-26
US4639468A (en) 1987-01-27
DE3010599A1 (de) 1980-10-09
NL191508B (nl) 1995-04-18
GB2048852A (en) 1980-12-17
NL8001721A (nl) 1980-09-24
AT381302B (de) 1986-09-25
CH645091A5 (fr) 1984-09-14
AU5678480A (en) 1980-09-25
DK162714B (da) 1991-12-02
AU536499B2 (en) 1984-05-10
IL59679A (en) 1984-11-30
FI82033B (fi) 1990-09-28

Similar Documents

Publication Publication Date Title
FR2451913B1 (cg-RX-API-DMAC10.html)
DE3050532A1 (cg-RX-API-DMAC10.html)
BR8002583A (cg-RX-API-DMAC10.html)
BR8006808A (cg-RX-API-DMAC10.html)
CS354380A2 (cg-RX-API-DMAC10.html)
FR2450031B3 (cg-RX-API-DMAC10.html)
FR2449432B3 (cg-RX-API-DMAC10.html)
FR2449847B1 (cg-RX-API-DMAC10.html)
FR2447511B1 (cg-RX-API-DMAC10.html)
FR2448690B3 (cg-RX-API-DMAC10.html)
FR2449838B1 (cg-RX-API-DMAC10.html)
FR2448512B1 (cg-RX-API-DMAC10.html)
FR2447156B1 (cg-RX-API-DMAC10.html)
FR2447123B1 (cg-RX-API-DMAC10.html)
FR2447104B1 (cg-RX-API-DMAC10.html)
CH655621B (cg-RX-API-DMAC10.html)
AU79826S (cg-RX-API-DMAC10.html)
AU79558S (cg-RX-API-DMAC10.html)
BR5901094U (cg-RX-API-DMAC10.html)
AU79918S (cg-RX-API-DMAC10.html)
AU79559S (cg-RX-API-DMAC10.html)
AU79950S (cg-RX-API-DMAC10.html)
AU80228S (cg-RX-API-DMAC10.html)
BG44800A1 (cg-RX-API-DMAC10.html)
BG28492A1 (cg-RX-API-DMAC10.html)